ResearcherUniversity of PennsylvaniaActive in the last 2 years
Uri Amit
Matched on ORCID iD 0000-0002-7499-7099; OpenAlex author ID A5081125374. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer. Co-author DOI 10.1002/cncr.35936↗
- Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Co-author DOI 10.1073/pnas.2403002121↗
- Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013. Co-author DOI 10.6004/jnccn.2017.0138↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Edgar Ben‐Josef · 2 shared papers, 2024–2025 · strength 0.40
- Paper A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resec… DOI 10.1002/cncr.35936↗
- Paper Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic can… DOI 10.1073/pnas.2403002121↗
- Charles M. Vollmer · 1 shared paper, 2025 · strength 0.21
- Thomas Benjamin Karasic · 1 shared paper, 2025 · strength 0.21
- John Peter Plastaras · 1 shared paper, 2025 · strength 0.21
- Andre A. Konski · 1 shared paper, 2025 · strength 0.21
- James M. Metz · 1 shared paper, 2025 · strength 0.21
- Erica L. Carpenter · 1 shared paper, 2025 · strength 0.21
- Kim A. Reiss-Binder · 1 shared paper, 2025 · strength 0.21
- Mark H. O’Hara · 1 shared paper, 2025 · strength 0.21
- Constantinos Koumenis Nahum · 1 shared paper, 2024 · strength 0.19
- Carl H. June · 1 shared paper, 2024 · strength 0.19
- Talia Golan · 1 shared paper, 2017 · strength 0.07
- Yaacov Richard Lawrence · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.